1Luka Z, Wagner C. Expression and purification of glycine N-methyltransferases in escherichia coli. Protein Expr Purif, 2003, 28 (2): 280-286.
2Schmmer P, Mehrabi A, Kraus T, et al. New aspects on reperfusion injury to liver-impact of organ harvest. Nephrol Dial Transplant, 2004, 19(Suppl 4): 26-35.
3McClain CJ, Hill DB, Song Z, et al. S-adenosylmethionine, cytokines,and alcoholic liver disease. Alcohol, 2002, 27 (3): 185-192.
4Halsted CH, Villanueva JA, Devlin AM, et al. Interactions of ethanol and folate deficiency in development of alcoholic liver disease in the micropig. Trans Am Clin Climatol Assoc, 2002, 113 (1): 151-162.
5Lieber CS. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. Curr Gastroenterol Rep, 2004, 6 (1): 60-65.
6Lee TD, Sadda MR, Mendler MH, et al. Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis. Alcohol Clin Exp Res, 2004, 28 (1): 173-181.
7Iinuma Y, Kubota M, Yagi M, et al. Whole blood manganese levels and brain manganese accumulation in children receiving long term home parenteral nutrition. Pediatr Surg Int, 2003, 19 (4): 268-272.
8Lanzini A, Tavonatti MG, Panarotto B, et al. Intestinal absorption of the bile acid analogue 75 Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut, 2003, 52 (9): 1371
9Overman GP, Teter CJ, Guthrie SK. Acamprosate for the adjunctive treatment of alcohol dependence. Ann Pharmacother, 2003, 37 (7-8): 1090-1099.
10Horie T, Sakaida I, Yokoya F, et al. L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation. Biochem Biophys Res Commun, 2003, 305 ( 1 ): 94-100.
